This content is from: Home

Tightening the generics loophole

Mexico's patent regime had, until recently, created a situation that allowed untested generics to come to market. But, says Luis Schmidt, a recent change in the law should improve standards

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial